Agnès Linglart chercheuse
Linglart, Agnès, 19..-....
Linglart, Agnès
VIAF ID: 217489809 (Personal)
Permalink: http://viaf.org/viaf/217489809
Preferred Forms
- 100 0 _ ‡a Agnès Linglart ‡c chercheuse
- 200 _ | ‡a Linglart ‡b Agnès
- 100 1 _ ‡a Linglart, Agnès, ‡d 19..-....
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Analyse prospective et biomécanique de la marche et des déformations osseuses chez les patients atteints de rachitisme hypophosphatémique lié au chromosome X | |
ASARM and dental pulp stem cells mineralization. | |
ASARM et biominéralisation de progéniteurs pulpaires | |
Atteinte osseuse et minérale chez l'enfant insuffisant rénal chronique : from bedside to bench | |
Compréhension de la physiopathologie de l'hypochondroplasie grâce à son modèle murin (Fgfr3Asn534Lys/+) | |
Contribution to human motion capture by stereovision and machine learning for gait analysis. | |
Déterminants de la croissance pubertaire des patients atteints de bloc en 21-hydroxylase, formes classiques et non classiques | |
Etude d'un locus soumis à empreinte parentale : le locus GNAS. Rôle des transcrits et maintien de l'empreinte | |
Facteurs de risque de calcifications intracérébrales chez les enfants suivis pour hypocalcémie | |
GNAS et empreinte parentale : Caractérisation des GNAS-miRNAs et d'une nouvelle DMR | |
Growth and insulin-like growth factors (IGF) : physiopathology insights from imprinting diseases. | |
Growth disorders analysis in hypochondroplasia mouse model and its therapeutic approaches. | |
High incidence of cranial synostosis and Chiari I malformation in children with X-linked hypophosphatemic rickets (XLHR) | |
Histoire naturelle de l'hypersensibilité à la vitamine D | |
Human dentin characteristics of patients with osteogenesis imperfecta: insights into collagen-based biomaterials | |
Hypophosphatasia: better knowledge for better care…. | |
Identification of new molecular defects underlying two diseases relating to growth in humans, the Beckwith-Wiedemann and Silver-Russell syndromes, through genetic and epigenetic approaches. | |
The Importance of Networking in Pseudohypoparathyroidism: EuroPHP Network and Patient Support Associations | |
Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci | |
Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations. | |
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. | |
Long-term outcome of liver transplantation in childhood: A study of 20-year survivors. | |
Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility | |
Magnetic Resonance Imaging Features as Surrogate Markers of X-Linked Hypophosphatemic Rickets Activity | |
Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations | |
Mitotane in pediatric Cushing's disease. | |
Near normalization of adult height and body proportions by growth hormone in pycnodysostosis | |
Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms | |
Nutritional management of cow's milk allergy in children: An update | |
Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia | |
[Osteoporosis in children with cerebral palsy] | |
Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs) | |
Pathologie phosphocalcique et osseuse de l'enfant | |
Physiopathologie parodontale et défauts de minéralisation dans le rachitisme vitamino-résistant hypophosphatémique. | |
Pineal cysts in children | |
Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone. | |
The Prevalence of GNAS Deficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network. | |
Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS. | |
Prospective and biomechanical analysis of gait and bone deformities in patients with X-linked hypophosphatemic rickets. | |
Pseudohypoparathyroidism type 1b, a model for studying genomic imprinting at the GNAS locus. | |
Puberty, fertility and chronic diseases | |
Puberty in subjects with complete androgen insensitivity syndrome | |
Recent Advances in Imprinting Disorders. | |
Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth | |
[Recommendations for the measurement of blood 25-OH vitamin D] | |
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance | |
Régulation épigénétique de la croissance fœtale : implication du gène soumis à empreinte parentale DLK1 (14q32) dans la croissance fœtale | |
Relationship between DNA methylation of IGF1 gene promoters and child growth variations. | |
Report of two novel mutations in PTHLH associated with brachydactyly type E and literature review. | |
Resistance to epinephrine and hypersensitivity (hyperresponsiveness) to CB1 antagonists in a patient with pseudohypoparathyroidism type Ic. | |
Risk of corrected QT interval prolongation after pamidronate infusion in children. | |
Rôle des claudines dans les jonctions serrées de la branche large ascendante corticale de l'anse de Henle | |
Role of AIP (Aryl Hydrocarbon Receptor Interacting Protein) in Pituitary Adenoma Tumorigenesis. | |
Role of claudins in thick ascending limb of Henle’s loop. | |
Role of delta-like homologue 1 (DLK1) on postnatal growth and somatotropic axis development. | |
[The role of gonadal peptides in clinical investigation]. | |
Role of the Gαq/11 intracellular pathway in the parathyroid hormone bone action : study in a bone specific Gαq/11 deficient mice with chronic renal failure. | |
Role of type I cAMP-dependent protein kinase in excitation-contraction coupling and heart failure. | |
Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program | |
SAT-039 GNAS-miRNAs Are Likely Involved in the Phenotype of Patients with Pseudohypoparathyroidism 1B/iPPSD3. | |
SAT-259 Natural History of Anthropometric Parametres of Obesity in Children Affected by X-Linked Hypophosphatemia: Longitudinal Obserbational Study. | |
Serum GH concentrations must now be expressed in mass units in France…as in the rest of the world. | |
Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. | |
Skeletal and extraskeletal disorders of biomineralization | |
Study of a Human Imprinted Locus : the GNAS Locus. Role of the GNAS Transcripts and Imprinting Maintenance. | |
SUN-529 Burden of Illness in Adults with Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry. | |
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature | |
Therapeutic management of hypophosphatemic rickets from infancy to adulthood. | |
Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia. | |
Tooth dentin defects reflect genetic disorders affecting bone mineralization | |
Topical Sodium Thiosulfate: A Treatment for Calcifications in Hyperphosphatemic Familial Tumoral Calcinosis? | |
Trabecular Bone Score: Where are we now? | |
Treatment of chronic hypocalcaemia during childhood | |
Treatment of heterotopic ossifications secondary to pseudohypoparathyroid. | |
Treatment with rhPTH in children | |
Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas. | |
[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement] | |
[When and how to treat a central precocious puberty?] |